Trials / Completed
CompletedNCT00015288
Buprenorphine and Naloxone Combination Study - 10
PK0496 Pharmacokinetics of Buprenorphine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.
Detailed description
The objective of this study is to examine pharmacokinetics and dose proportionality of sublingual tablets containing varying doses of buprenorphine and naloxone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine/naloxone |
Timeline
- Start date
- 1996-11-01
- First posted
- 2001-04-18
- Last updated
- 2017-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00015288. Inclusion in this directory is not an endorsement.